Loading…
TZS 8,000
In stock
DIAZAC 5MG TABLETS CONTAIN DAPAGLIFLOZIN, AN ORAL ANTIDIABETIC MEDICINE BELONGING TO THE SODIUM-GLUCOSE COTRANSPORTER-2 (SGLT2) INHIBITOR CLASS. IT WORKS BY REDUCING GLUCOSE REABSORPTION IN THE KIDNEYS, ALLOWING EXCESS GLUCOSE TO BE REMOVED FROM THE BODY THROUGH URINE. IT IS USED TO IMPROVE BLOOD SUGAR CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS. DAPAGLIFLOZIN MAY ALSO BE PRESCRIBED FOR CERTAIN PATIENTS WITH HEART FAILURE OR CHRONIC KIDNEY DISEASE, SUBJECT TO THE APPROVED INDICATION AND APPROPRIATE DOSING.
